In the latest decision addressing the patentability of Myriad’s BRCA1- and BRCA2-related patents, the U. S. Court of Appeals for the Federal Circuit
The Supreme Court of the United States has released its highly anticipated decision in AMP et al. v. Myriad Genetics, Inc., et al., on the patenting
It has long been held that inventions reflecting the “hand of man” may be patented.
The Intellectual Property Owners Association (IPO) and the U.S. Department of Justice (DOJ) are two of at least 15 parties that have filed briefs as friends of the court in the Association for Molecular Pathology v. U.S. Patent and Trademark Office and Myriad Genetics, Inc.
May a gene be patented?
The U.S. District Court for the Southern District of New York granted the plaintiffs’ motion for summary judgment in the closely watched case Association for Molecular Pathology, et al v. USPTO and Myriad, et al.
Judge Sweet held that products isolated from nature must possess "markedly different characteristics" from the product in nature to constitute patentable subject matter.